* Nurix Therapeutics press release [https://seekingalpha.com/pr/20261446-nurix-therapeutics-reports-third-quarter-2025-financial-results-and-provides-a-corporate] (NASDAQ:NRIX [https://seekingalpha.com/symbol/NRIX]): Q3 GAAP EPS of -$1.03 misses by $0.11.
* Revenue of $7.9M (-37.3% Y/Y) misses by $4.33M.
* _Cash, cash equivalents and marketable securities__ _were $428.8 million as of August 31, 2025, compared to $609.6 million as of November 30, 2024.
MORE ON NURIX THERAPEUTICS
* Nurix Therapeutics, Inc. (NRIX) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 (Transcript) [https://seekingalpha.com/article/4821948-nurix-therapeutics-inc-nrix-presents-at-wells-fargo-20th-annual-healthcare-conference-2025]
* Nurix Therapeutics, Inc. (NRIX) Presents At Baird Global Healthcare Conference 2025 (Transcript) [https://seekingalpha.com/article/4822028-nurix-therapeutics-inc-nrix-presents-at-baird-global-healthcare-conference-2025-transcript]
* Nurix Therapeutics, Inc. (NRIX) Presents At H.C. Wainwright 27th Annual Global Investment Conference Transcript [https://seekingalpha.com/article/4821927-nurix-therapeutics-inc-nrix-presents-at-h-c-wainwright-27th-annual-global-investment]
* Seeking Alpha’s Quant Rating on Nurix Therapeutics [https://seekingalpha.com/symbol/NRIX/ratings/quant-ratings]
* Historical earnings data for Nurix Therapeutics [https://seekingalpha.com/symbol/NRIX/earnings]
Nurix Therapeutics GAAP EPS of -$1.03 misses by $0.11, revenue of $7.9M misses by $4.33M
Published 1 month ago
Oct 10, 2025 at 6:44 AM
Negative
Auto